[The treatment of asthma].
As asthma is a chronic, predominantly inflammatory process, maintenance therapy must be emphasized. It consists in most patients to regularly inhale a steroid agent (fluticasone or budesonide), in combination with non pharmacological interventions and occasional inhalation, as needed, of a short-acting sympathomimetic agent. When single therapy with an inhaled steroid is not sufficiently efficient, adding a long-acting sympathomimetic agent (salmeterol or formeterol) is recommended. Treatment of acute asthma includes repeated administration, at short interval, of an inhaled sympathomimetic agent (salbutamol or terbutaline) combined with oxygen and a systemic corticosteroid.
Noseda
A
A
Département de Médecine, C.H.U. Brugmann, U.L.B.
D000208:Acute Disease; D000280:Administration, Inhalation; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000628:therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D013566:Sympathomimetics / Q000627:therapeutic use
D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D013566:Sympathomimetics